OXFORD, United Kingdom, and BALTIMORE, Dec. 13, 2021 (GLOBE nNEWSWIRE) -- Vaccitech plc (NASDAQ: VACC), a clinical-stage nbiopharmaceutical company engaged in the discovery and development of nnovel immunotherapies and vaccines, today announced that it has acquirednUS-based Avidea Technologies, Inc. (“Avidea”).